And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

BCAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.38%

Insider Buying (Last 12 Months): $162,400.00

Insider Selling (Last 12 Months): $0.00

BioAtla Insider Trading History Chart

BioAtla Share Price & Price History

^$2.43

▼ -0.1 (-3.95%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

BioAtla Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/26/2023	Sylvia Mcbrinn	Director	Buy	4,000	$2.33	$9,320.00	15,125
12/20/2023	Jay M. Short	CEO	Buy	50,000	$2.14	$107,000.00	1,439,283
12/19/2023	Lawrence Steinman	Director	Buy	20,000	$2.05	$41,000.00	38,459
9/8/2023	Sylvia Mcbrinn	Director	Buy	2,000	$2.54	$5,080.00	11,125
3/29/2023	Jay M. Short	CEO	Buy	40,800	$2.47	$100,776.00	1,412,387
3/28/2023	Christian Vasquez	Insider	Buy	20,000	$2.40	$48,000.00	102,709
12/19/2022	Sylvia Mcbrinn	Director	Buy	3,700	$8.33	$30,821.00	9,125
11/22/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.27	$16,540.00	5,425
9/12/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.85	$17,700.00	2,000
8/12/2022	Jay M. Short	CEO	Buy	26,350	$7.84	$206,584.00	1,396,556
6/21/2022	Jay M. Short	CEO	Buy	29,082	$2.79	$81,138.78	1,335,674
6/9/2022	Christian Vasquez	Insider	Buy	10,000	$2.97	$29,700.00	74,525
6/7/2022	Christian Vasquez	Insider	Buy	14,152	$3.04	$43,022.08	38,677
12/1/2021	Christian Vasquez	Insider	Sell	1,011	$23.04	$23,293.44
12/1/2021	Jay M. Short	CEO	Sell	24,321	$23.03	$560,112.63
12/1/2021	Richard A. Waldron	CFO	Sell	7,246	$23.03	$166,875.38
12/1/2021	Scott Andrew Smith	President	Sell	628	$23.03	$14,462.84
11/29/2021	Christian Vasquez	Insider	Sell	642	$23.89	$15,337.38
11/29/2021	Jay M. Short	CEO	Sell	15,435	$23.89	$368,742.15
11/29/2021	Richard A. Waldron	CFO	Sell	4,599	$23.89	$109,870.11
11/29/2021	Scott Andrew Smith	President	Sell	399	$23.89	$9,532.11
11/24/2021	Christian Vasquez	Insider	Sell	750	$24.87	$18,652.50
11/24/2021	Jay M. Short	CEO	Sell	17,022	$24.87	$423,337.14
11/24/2021	Richard A. Waldron	CFO	Sell	3,937	$24.87	$97,913.19
11/24/2021	Scott Andrew Smith	President	Sell	466	$24.87	$11,589.42
11/22/2021	Christian Vasquez	Insider	Sell	691	$26.23	$18,124.93
11/22/2021	Jay M. Short	CEO	Sell	15,675	$26.23	$411,155.25
11/22/2021	Richard A. Waldron	CFO	Sell	3,626	$26.23	$95,109.98
11/22/2021	Scott Andrew Smith	President	Sell	430	$26.23	$11,278.90
11/2/2021	Lawrence Steinman	Director	Sell	450	$30.00	$13,500.00
10/1/2021	Eric Sievers	Insider	Sell	592	$30.39	$17,990.88
10/1/2021	Scott Andrew Smith	President	Sell	2,994	$30.18	$90,358.92
9/15/2021	Lawrence Steinman	Director	Sell	450	$36.82	$16,569.00
8/26/2021	Eric Sievers	Insider	Sell	6,883	$39.59	$272,497.97	93,766
8/26/2021	Scott Andrew Smith	President	Sell	33,244	$40.16	$1,335,079.04	368,568
8/24/2021	Guy Levy	Director	Sell	546,709	$39.65	$21,677,011.85
8/24/2021	Jay M. Short	CEO	Sell	4,533	$41.60	$188,572.80	1,441,508
8/16/2021	Lawrence Steinman	Director	Sell	450	$40.60	$18,270.00
7/15/2021	Lawrence Steinman	Director	Sell	450	$38.29	$17,230.50
6/21/2021	Jay M. Short	CEO	Sell	55,000	$39.13	$2,152,150.00	1,441,508
6/17/2021	Jay M. Short	CEO	Sell	19,269	$39.22	$755,730.18	1,441,508

New crypto project uncovers 2,050% in 65 days

From InvestorPlace | Ad

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SEC Filings (Institutional Ownership Changes) for BioAtla (NASDAQ:BCAB)

77.23% of BioAtla stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioAtla Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/12/2024	PVG Asset Management Corp	65,335	$0.16M	0.8%	N/A	0.136%
3/11/2024	Vanguard Group Inc.	2,081,370	$5.12M	0.0%	-1.0%	4.342%
3/1/2024	Goldman Sachs Group Inc.	38,751	$95K	0.0%	-21.1%	0.081%
2/26/2024	Perceptive Advisors LLC	73,000	$0.18M	0.0%	N/A	0.152%
2/15/2024	Wexford Capital LP	11,830	$29K	0.0%	N/A	0.025%
2/15/2024	Barclays PLC	60,893	$0.15M	0.0%	+666.6%	0.127%
2/15/2024	Vanguard Group Inc.	2,081,370	$5.12M	0.0%	-1.0%	4.342%
2/15/2024	Nuveen Asset Management LLC	177,852	$0.44M	0.0%	+3.5%	0.371%
2/15/2024	Bridgeway Capital Management LLC	100,000	$0.25M	0.0%	-10.7%	0.209%
2/14/2024	Pale Fire Capital SE	48,383	$0.12M	0.0%	+204.6%	0.101%
2/13/2024	Envestnet Asset Management Inc.	17,978	$44K	0.0%	N/A	0.038%
2/13/2024	Goldman Sachs Group Inc.	38,751	$95K	0.0%	-21.1%	0.081%
2/9/2024	Norges Bank	488,191	$1.20M	0.0%	N/A	1.018%
2/8/2024	Panagora Asset Management Inc.	111,366	$0.27M	0.0%	+110.0%	0.232%
2/7/2024	Formidable Asset Management LLC	154,246	$0.38M	0.1%	-5.3%	0.322%
2/7/2024	Dimensional Fund Advisors LP	210,758	$0.52M	0.0%	-18.7%	0.440%
2/2/2024	Simplex Trading LLC	11,926	$29K	0.0%	-71.3%	0.025%
2/1/2024	SC&H Financial Advisors Inc.	65,519	$0.16M	0.0%	-7.9%	0.137%
1/30/2024	Vontobel Holding Ltd.	706,062	$1.74M	0.0%	-1.3%	1.473%
1/1/2024	Vanguard Group Inc.	2,102,316	$3.57M	0.0%	+0.2%	4.385%
11/30/2023	American Century Companies Inc.	24,897	$42K	0.0%	+34.7%	0.052%
11/24/2023	Deutsche Bank AG	279,122	$0.48M	0.0%	-59.7%	0.582%
11/15/2023	Toroso Investments LLC	160,294	$0.27M	0.0%	+81.3%	0.335%
11/15/2023	Sectoral Asset Management Inc.	706,062	$1.20M	0.2%	+26.9%	1.477%
11/15/2023	Adage Capital Partners GP L.L.C.	1,796,148	$3.05M	0.0%	-5.2%	3.757%
11/15/2023	Affinity Asset Advisors LLC	180,000	$0.31M	0.1%	-44.6%	0.377%
11/13/2023	Northern Trust Corp	357,360	$0.61M	0.0%	-2.0%	0.748%
11/9/2023	Formidable Asset Management LLC	162,794	$0.28M	0.1%	+79.0%	0.341%
11/9/2023	Deutsche Bank AG	279,122	$0.48M	0.0%	-59.7%	0.584%
11/8/2023	Vivo Capital LLC	534,181	$0.91M	0.1%	-16.2%	1.118%
11/8/2023	Massachusetts Financial Services Co. MA	528,667	$0.90M	0.0%	-30.1%	1.106%
10/31/2023	Panagora Asset Management Inc.	53,030	$90K	0.0%	N/A	0.111%
10/30/2023	SC&H Financial Advisors Inc.	71,125	$0.12M	0.0%	+232.4%	0.149%
10/13/2023	SG Americas Securities LLC	21,963	$37K	0.0%	N/A	0.046%
10/11/2023	Vontobel Holding Ltd.	715,195	$1.22M	0.0%	+26.4%	1.496%
9/21/2023	Barclays PLC	8,827	$27K	0.0%	N/A	0.018%
8/21/2023	California State Teachers Retirement System	14,714	$44K	0.0%	N/A	0.031%
8/16/2023	Nuveen Asset Management LLC	229,345	$0.69M	0.0%	N/A	0.480%
8/15/2023	Wells Fargo & Company MN	16,867	$51K	0.0%	+5,254.6%	0.035%
8/15/2023	XTX Topco Ltd	110,512	$0.33M	0.1%	N/A	0.231%
8/15/2023	Goldman Sachs Group Inc.	82,219	$0.25M	0.0%	+44.9%	0.172%
8/15/2023	Kennedy Capital Management LLC	29,052	$87K	0.0%	N/A	0.061%
8/14/2023	State Street Corp	712,269	$2.14M	0.0%	+434.7%	1.490%
8/14/2023	Nuveen Asset Management LLC	229,345	$0.69M	0.0%	N/A	0.480%
8/11/2023	Renaissance Technologies LLC	687,472	$2.06M	0.0%	+49.9%	1.442%
8/11/2023	Pale Fire Capital SE	15,883	$48K	0.0%	N/A	0.033%
8/11/2023	BlackRock Inc.	3,198,782	$9.60M	0.0%	+225.2%	6.710%
8/11/2023	MYDA Advisors LLC	60,000	$0.18M	0.1%	+9.1%	0.126%
8/11/2023	Sectoral Asset Management Inc.	556,518	$1.67M	0.3%	+2.5%	1.167%
8/11/2023	State Board of Administration of Florida Retirement System	12,560	$38K	0.0%	N/A	0.026%
8/11/2023	The Manufacturers Life Insurance Company	19,389	$58K	0.0%	N/A	0.041%
8/11/2023	Geode Capital Management LLC	831,076	$2.49M	0.0%	+121.4%	1.743%
8/11/2023	JPMorgan Chase & Co.	45,366	$0.14M	0.0%	+350.3%	0.095%
8/11/2023	Northern Trust Corp	364,778	$1.09M	0.0%	+303.5%	0.765%
8/10/2023	MetLife Investment Management LLC	24,978	$75K	0.0%	N/A	0.052%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	26,899	$81K	0.0%	N/A	0.056%
8/10/2023	Charles Schwab Investment Management Inc.	119,549	$0.36M	0.0%	+548.5%	0.251%
8/10/2023	Citigroup Inc.	13,979	$42K	0.0%	+2,552.6%	0.029%
8/8/2023	Wasatch Advisors LP	1,500,934	$4.50M	0.0%	+18.4%	3.149%
8/4/2023	American International Group Inc.	21,290	$64K	0.0%	N/A	0.045%
8/3/2023	Barclays PLC	8,827	$27K	0.0%	N/A	0.019%
8/3/2023	Bank of New York Mellon Corp	133,004	$0.40M	0.0%	+565.0%	0.279%
8/2/2023	Bank of Montreal Can	16,078	$62K	0.0%	N/A	0.034%
7/24/2023	Vontobel Holding Ltd.	565,651	$1.70M	0.0%	+2.4%	1.187%
7/13/2023	Transcend Capital Advisors LLC	49,000	$0.15M	0.0%	N/A	0.103%
6/1/2023	Prelude Capital Management LLC	12,846	$34K	0.0%	-20.6%	0.027%
5/23/2023	Toroso Investments LLC	88,435	$0.24M	0.0%	+157.4%	0.186%
5/18/2023	JPMorgan Chase & Co.	10,074	$27K	0.0%	-93.9%	0.021%
5/16/2023	Jane Street Group LLC	115,163	$0.31M	0.0%	+106.0%	0.242%
5/16/2023	State Street Corp	133,206	$0.36M	0.0%	+11.4%	0.280%
5/16/2023	Squarepoint Ops LLC	19,179	$51K	0.0%	+28.4%	0.040%
5/16/2023	Geode Capital Management LLC	375,434	$1.01M	0.0%	+6.6%	0.789%
5/15/2023	Cubist Systematic Strategies LLC	43,929	$0.12M	0.0%	+65.1%	0.092%
5/15/2023	Affinity Asset Advisors LLC	325,000	$0.87M	0.3%	+116.7%	0.683%
5/15/2023	Two Sigma Advisers LP	352,200	$0.94M	0.0%	+0.9%	0.740%
5/15/2023	Two Sigma Investments LP	294,581	$0.79M	0.0%	+1.9%	0.619%
5/15/2023	Deutsche Bank AG	692,390	$1.86M	0.0%	+73.7%	1.454%
5/15/2023	Atom Investors LP	55,476	$0.15M	0.1%	+71.9%	0.117%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	512,300	$1.37M	0.0%	N/A	1.076%
5/15/2023	MYDA Advisors LLC	55,000	$0.15M	0.1%	N/A	0.116%
5/12/2023	Renaissance Technologies LLC	458,600	$1.23M	0.0%	-4.3%	0.963%
5/12/2023	Wasatch Advisors LP	1,268,169	$3.40M	0.0%	+119.0%	2.664%
5/12/2023	Candriam S.C.A.	1,565,406	$3.86M	0.0%	-13.3%	3.288%
5/12/2023	BlackRock Inc.	983,512	$2.64M	0.0%	-3.1%	2.066%
5/12/2023	Sectoral Asset Management Inc.	543,009	$1.46M	0.3%	+292.6%	1.141%
5/12/2023	Bank of America Corp DE	20,007	$54K	0.0%	-58.4%	0.042%
5/12/2023	Wellington Management Group LLP	365,228	$0.98M	0.0%	N/A	0.767%
5/11/2023	Acadian Asset Management LLC	92,683	$0.25M	0.0%	+71.3%	0.195%
5/11/2023	Cornercap Investment Counsel Inc.	61,534	$0.17M	0.0%	+89.0%	0.129%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	48,614	$0.13M	0.0%	N/A	0.102%
5/9/2023	Formidable Asset Management LLC	90,935	$0.24M	0.1%	+162.8%	0.191%
5/9/2023	Tower Research Capital LLC TRC	11,295	$30K	0.0%	+71.6%	0.024%
5/3/2023	Jump Financial LLC	46,800	$0.13M	0.0%	N/A	0.098%
5/1/2023	Virtu Financial LLC	10,302	$28K	0.0%	N/A	0.022%
4/12/2023	Vontobel Holding Ltd.	552,142	$1.48M	0.0%	+274.5%	1.160%
2/15/2023	Jane Street Group LLC	55,902	$0.46M	0.0%	+337.9%	0.149%
2/15/2023	Toroso Investments LLC	34,355	$0.28M	0.0%	-16.0%	0.091%
2/15/2023	Silverarc Capital Management LLC	546,875	$4.51M	1.3%	+172.9%	1.454%
2/15/2023	Sphera Funds Management LTD.	186,600	$1.54M	0.3%	N/A	0.496%
2/15/2023	Soleus Capital Management L.P.	4,220,397	$34.82M	5.0%	+24.1%	11.221%

Data available starting January 2016

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC), which is in Phase II clinical trial for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC that is in Phase II clinical trial for the treatment of melanoma and squamous cell cancer of the head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody, which is in Phase II clinical trial for treating melanoma, carcinomas, and NSCLC; and BA3182, a bispecific candidate that is in Phase 1 study for the treatment of adenocarcinomas, as well as BA3361, which is in preclinical studies for treating multiple tumor types. The company was founded in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $2.43

$2.39

$2.55

50 Day Range

MA: $2.82

$2.26

$3.92

52 Week Range

Now: $2.43

$1.24

$4.07

Volume

361,731 shs

Average Volume

500,771 shs

Market Capitalization

$116.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08

Who are the company insiders with the largest holdings of BioAtla?: BioAtla's top insider shareholders include:
Jay M Phd Short (CEO)
Christian Vasquez (Insider)
Lawrence Steinman (Director)
Sylvia Mcbrinn (Director)
Learn More about top insider investors at BioAtla.

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here